LifeMine Therapeutics

LifeMine is a clinical-stage biopharmaceutical company pioneering a bold new approach, Top-Down Drug DiscoveryTM, which leverages evolutionary insights from fungi to unearth next-generation precision medicines.

Health and bio

Latest funding

$188M Series B+ · August 6, 2026

Led by Milky Way Investments · Source: fundraisingfox.com

Total raised: $543M across 5 sourced rounds

All 5 rounds ↓

Website: lifeminetx.com.

X: @LifeMineTx · 5 followers.

LinkedIn: lifemine-therapeutics.

Category: Health and bio.

Sectors: Biopharma, Biotechnology, Clinical Trials, Life Science, Precision Medicine.

Stage: Series B+.

Based in: Cambridge, United States.

Founded: 2016.

Total raised: $543M in 5 sourced rounds.

Last round: Aug 6, 2026 · 101 days ago.

Headcount: 101–250 employees.

On Recent Funding since: Sep 29, 2026.

Signals

X account@LifeMineTx · created Mar 14, 2019 (7 years old) · 5 followers

Website registeredAug 1, 2016 (10 years old)

TIMELINE · MONEY RAISED

LifeMine Therapeutics | 413 days from website to first raise on record

@LifeMineTx·Raised $543M in 5 sourced rounds·1 signal before the first raise

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

Date	Round	Amount	Lead	Source
Aug 6, 2026	Series B+	$188M	MMilky Way Investments	fundraisingfox.com
Aug 6, 2026	Series B+	$75M	MMilky Way Investments	biospace.com
Mar 23, 2022	Series B+	$175M	FFidelity Management & Research Company	fundraisingfox.com
Jan 7, 2021	Series B+	$50M	MMilky Way Investments	biospace.com
Sep 18, 2017	Series A	$55M	WWuXi Healthcare Ventures	biospace.com

Timeline

March 14, 2019
X account created
August 1, 2016
Website created

Founders and team

GV
Gregory Verdine Founder

LinkedIn
HH
Hingge Hsu Founder
RK
Rick Klausner Founder

LinkedIn
WZ
Weiqing Zhou Founder

LinkedIn
HD
Hongyue Dai VP, Translational Bioinformatics
JC
Jared Cumming SVP & Head of Chemistry
KG
Karen Guarco Senior Vice President of Finance and Research Operations of Finance
MS
Martin Stahl Chief Scientific Officer
PC
Paola Castaldi Vice President of Chemical Biology & Proteomics
TR
Tom Ramseier VP of Synthetic Biology
YZ
Yves Zinggeler Chief Commercial Officer

Investors

Companies like LifeMine Therapeutics

IIDRx$120M Series B+ · Aug 2024
DDelphia Therapeutics$67M Series A · May 2024
FFoRx Therapeutics$50M Series A · Dec 2025
CCoultreon$125M Series A · Apr 2026
CCellCentric$220M Series B+ · May 2026
BBionyra$165M Series A · Jun 2026

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/lifemine-therapeutics (get a free API key).